Page last updated: 2024-08-16

sumatriptan and avitriptan

sumatriptan has been researched along with avitriptan in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bax, WA; De Vries, P; Heiligers, JP; Maassen vandenBrink, A; Saxena, PR; Wang, W; Yocca, FD1
Bax, WA; Ferrari, MD; MaassenVanDenBrink, A; Reekers, M; Saxena, PR1
Dahlöf, CG; Falk, L; Lewis, CP; Risenfors, M1
Cutler, NR; Ford, NF; Fulmor, IE; Jhee, SS; Salazar, DE; Sramek, JJ1
Edvinsson, L; Goadsby, PJ; Knight, YE1

Trials

2 trial(s) available for sumatriptan and avitriptan

ArticleYear
Safety trial with the 5HT1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptan.
    Cephalalgia : an international journal of headache, 1998, Volume: 18, Issue:8

    Topics: Adult; Chest Pain; Diagnosis, Differential; Electrocardiography; Electrocardiography, Ambulatory; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Myocardial Ischemia; Neck Pain; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Safety; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Tryptamines; Ultrasonography

1998
A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hypertension.
    Cephalalgia : an international journal of headache, 1999, Volume: 19, Issue:2

    Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Sulfonamides; Sumatriptan; Tryptamines

1999

Other Studies

3 other study(ies) available for sumatriptan and avitriptan

ArticleYear
Effects of avitriptan, a new 5-HT 1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential.
    Naunyn-Schmiedeberg's archives of pharmacology, 1997, Volume: 355, Issue:2

    Topics: Animals; Arteriovenous Anastomosis; Blood Pressure; Carotid Arteries; Coronary Vessels; Head; Heart Rate; Hemodynamics; Humans; Indoles; Migraine Disorders; Muscle Contraction; Muscle, Smooth, Vascular; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Swine; Tryptamines; Vasoconstrictor Agents

1997
Coronary side-effect potential of current and prospective antimigraine drugs.
    Circulation, 1998, Jul-07, Volume: 98, Issue:1

    Topics: Adolescent; Adult; Aged; Angina Pectoris; Child; Coronary Vessels; Dihydroergotamine; Ergotamine; Female; Humans; In Vitro Techniques; Indoles; Male; Methysergide; Middle Aged; Migraine Disorders; Piperidines; Sulfonamides; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents

1998
Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Neuropeptides, 1999, Volume: 33, Issue:1

    Topics: Animals; Calcitonin Gene-Related Peptide; Cats; Cerebral Arteries; Cerebrovascular Circulation; Cranial Sinuses; Electric Stimulation; Indoles; Jugular Veins; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Trigeminal Nerve; Tryptamines

1999